By Denny Jacob
--Johnson & Johnson is in talks to acquire Intra-Cellular Therapies, says Bloomberg, citing people familiar with the matter.
--A deal could be reached as soon as this week, according to the report. While discussions are ongoing, they may not lead to an agreement and other suitors could also emerge, it added.
--If announced, the deal would be the biggest biotech transaction in more than a year, according to Bloomberg.
--A representative for J&J declined to comment, while a spokesperson for Intra-Cellular couldn't immediately be reached for comment, according to the report.
Full story at https://www.bloomberg.com/news/articles/2025-01-12/johnson-johnson-exploring-bid-for-intra-cellular
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
January 13, 2025 06:25 ET (11:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.